SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-22-043137
Filing Date
2022-08-01
Accepted
2022-08-01 06:06:41
Documents
2
Group Members
DANIEL B. ASHERMITCHELL P. KOPIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea163624-13gintra_kiora.htm SC 13G 66009
2 JOINT FILING AGREEMENT ea163624ex99-1_kiora.htm EX-99.1 4099
  Complete submission text file 0001213900-22-043137.txt   71761
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Subject) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88748 | Film No.: 221122667
SIC: 2834 Pharmaceutical Preparations

Mailing Address 245 PALM TRAIL DELRAY BEACH FL 33483
Business Address 245 PALM TRAIL DELRAY BEACH FL 33483 8475629030
INTRACOASTAL CAPITAL, LLC (Filed by) CIK: 0001646799 (see all company filings)

IRS No.: 320460881 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G